CytoDyn (CYDY) Depreciation & Amortization (CF) (2010 - 2026)
CytoDyn (CYDY) posted Depreciation & Amortization (CF) of $4000.0 for Q1 2026, down 20.0% on a QoQ basis from $5000.0 in Q4 2025, and down 20.0% year-over-year from $5000.0 in Q1 2025.
CytoDyn (CYDY) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
CytoDyn's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $4000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 20.0% year-over-year to $4000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $17000.0 (down 5.56% YoY) and the FY2025 annual result came in at $18000.0, down 37.93% from the prior year.
- Depreciation & Amortization (CF) was $4000.0 for Q1 2026 at CytoDyn, down from $5000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $129000.0 in Q1 2022 and bottomed at $4000.0 in Q2 2024.
- A 5-year average of $28705.9 and a median of $7000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) slumped 91.94% — and 2025, when it climbed 25.0%.
- CytoDyn's Depreciation & Amortization (CF) stood at $54000.0 in 2022, then slumped by 85.19% to $8000.0 in 2023, then plunged by 50.0% to $4000.0 in 2024, then increased by 25.0% to $5000.0 in 2025, then declined by 20.0% to $4000.0 in 2026.
- Business Quant data shows CYDY's Depreciation & Amortization (CF) at $4000.0 in Q1 2026, $5000.0 in Q4 2025, and $4000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | CytoDyn | 267.79 Mn | 267.79 Mn | - | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 4,000.00 |
| Feb 28, 2026 | 4,000.00 |
| Nov 30, 2025 | 5,000.00 |
| Nov 30, 2025 | 5,000.00 |
| Aug 31, 2025 | 4,000.00 |
| Aug 31, 2025 | 4,000.00 |
| May 31, 2025 | 4,000.00 |
| May 31, 2025 | 4,000.00 |
| Feb 28, 2025 | 5,000.00 |
| Feb 28, 2025 | 5,000.00 |
| Nov 30, 2024 | 4,000.00 |
| Nov 30, 2024 | 4,000.00 |
| Aug 31, 2024 | 5,000.00 |
| Aug 31, 2024 | 5,000.00 |
| May 31, 2024 | 4,000.00 |
| May 31, 2024 | 4,000.00 |
| Feb 29, 2024 | 7,000.00 |
| Feb 29, 2024 | 7,000.00 |
| Nov 30, 2023 | 8,000.00 |
| Nov 30, 2023 | 8,000.00 |